Your browser is no longer supported. Please, upgrade your browser.
Settings
GSK GlaxoSmithKline plc daily Stock Chart
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E15.60 EPS (ttm)2.62 Insider Own0.20% Shs Outstand2.48B Perf Week-0.05%
Market Cap102.19B Forward P/E13.71 EPS next Y2.98 Insider Trans0.00% Shs Float2.50B Perf Month-3.13%
Income6.58B PEG4.73 EPS next Q0.47 Inst Own12.60% Short Float0.38% Perf Quarter-2.46%
Sales43.00B P/S2.38 EPS this Y22.80% Inst Trans6.09% Short Ratio1.83 Perf Half Y-6.90%
Book/sh6.45 P/B6.34 EPS next Y1.81% ROA6.90% Target Price48.25 Perf Year2.25%
Cash/sh2.37 P/C17.22 EPS next 5Y3.30% ROE54.00% 52W Range31.43 - 48.25 Perf YTD-12.98%
Dividend1.89 P/FCF26.77 EPS past 5Y10.30% ROI14.30% 52W High-15.25% Beta0.74
Dividend %4.62% Quick Ratio0.60 Sales past 5Y8.00% Gross Margin68.20% 52W Low30.10% ATR0.86
Employees99437 Current Ratio0.90 Sales Q/Q18.70% Oper. Margin21.50% RSI (14)50.77 Volatility1.49% 1.53%
OptionableYes Debt/Eq2.44 EPS Q/Q87.40% Profit Margin15.30% Rel Volume0.31 Prev Close41.03
ShortableYes LT Debt/Eq1.89 Earnings- Payout28.60% Avg Volume5.22M Price40.89
Recom2.00 SMA20-2.16% SMA503.94% SMA200-4.12% Volume1,610,214 Change-0.34%
Feb-12-20Downgrade Shore Capital Hold → Sell
Jan-16-20Downgrade Barclays Equal Weight → Underweight
Dec-02-19Initiated SVB Leerink Outperform
Nov-21-19Upgrade UBS Neutral → Buy
Oct-11-19Upgrade Cantor Fitzgerald Hold → Buy
Sep-03-19Upgrade Societe Generale Sell → Buy
Sep-03-19Resumed Citigroup Neutral
Aug-13-19Resumed JP Morgan Neutral
Jun-17-19Resumed Morgan Stanley Underweight
Mar-08-19Downgrade Shore Capital Buy → Hold
Feb-22-19Downgrade UBS Buy → Neutral
Jan-14-19Downgrade Exane BNP Paribas Outperform → Neutral
Dec-11-18Resumed Jefferies Buy
Oct-09-18Initiated Guggenheim Neutral
Aug-30-18Downgrade Liberum Buy → Hold
Apr-04-18Upgrade Exane BNP Paribas Neutral → Outperform
Mar-22-18Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-09-18Upgrade Kepler Reduce → Hold
Nov-06-17Downgrade Investec Buy → Hold
Oct-26-17Downgrade BofA/Merrill Buy → Neutral
May-24-20 08:21AM  An 'unprecedented' effort to find a coronavirus vaccine has over 100 horses in the race Yahoo Finance
May-23-20 09:15AM  Some wellness products growing over 1,000% during pandemic: Ro CEO Yahoo Finance
May-22-20 03:43PM  Profit from the Genomics Market Momentum With These ETFs Zacks
10:31AM  A Covid-19 Vaccine Could Be Ready Late This Year, Bernstein Analyst Says Barrons.com
10:13AM  European stocks struggle amid tensions surrounding China, but head for weekly gain MarketWatch
07:46AM  Telehealth is going to 'become the default' for patients: Ro CEO Yahoo Finance
07:29AM  Everything you need to know about the Oxford University vaccine and other efforts to beat coronavirus MarketWatch
05:37AM  Pharma Stock Roundup: FDA Ok's Cancer Drugs for New Use, JNJ Stops US Baby Powder Sales Zacks
May-21-20 10:41PM  South Korea's Samsung Biologics signs $231 million supply deal with GSK Reuters
10:00PM  S.Korea's Samsung Biologics signs $231 mln supply deal with GSK Reuters
07:11PM  GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio PR Newswire
03:48PM  Fmr. CDC Official: 'were not cutting any corners' on COVID-19 vaccine development Yahoo Finance Video
02:24PM  Clovis Oncology Needs a Savior GuruFocus.com
02:04PM  GlaxoSmithKline Teams Up With Mammoth Biosciences on a CRISPR-Based COVID-19 Test Motley Fool
05:17AM  Gilead, Galapagos Announce Positive Data on Inflammatory Drug Zacks
May-20-20 12:00PM  GSK ties up with gene editing start-up Mammoth for COVID-19 test Reuters
11:49AM  U.K. investors have lost out on more than £30 billion in dividends. It is about to get worse, say analysts. MarketWatch
08:11AM  Better Buy: GlaxoSmithKline vs. Pfizer Motley Fool
May-19-20 02:59PM  GlaxoSmithKline, Pfizer, and Shionogi's HIV Prevention Candidate Outperforms Gilead's Truvada Motley Fool
11:39AM  Glaxo's Long-Acting HIV Injection Effective Than Daily Pills Zacks
11:39AM  A Covid-19 Vaccine Could Be Worth Billions for Moderna and Its Rivals Barrons.com
10:44AM  Moderna Rallies on Encouraging Coronavirus Vaccine Study Data Zacks
07:02AM  Where Will Adaptimmune Be in 5 Years? Motley Fool
May-18-20 08:32PM  PRESS DIGEST- British Business - May 19 Reuters
03:10PM  Modernas stock soars on compelling early data for its coronavirus vaccine candidate MarketWatch
11:20AM  Who Is Winning the COVID-19 Vaccine Race? Investopedia
10:03AM  3 ETFs in Focus as Race for Vaccine Intensifies Investopedia
09:00AM  Pfizer Just Began A Coronavirus Vaccine Test Is PFE Stock A Buy? Investor's Business Daily
05:05AM  Identification and Characterization of a Potential Therapeutic COVID-19 Antibody by Vir Biotechnology Published in Nature GlobeNewswire
02:58AM  GSK's long-acting injection beats Truvada in HIV prevention trial Reuters
02:29AM  Glaxo-held firm ends HIV study early as injectable shows higher efficacy than daily pill MarketWatch
May-15-20 07:16PM  Inside the Science and Companies Racing to Develop a Covid-19 Vaccine Barrons.com
02:23PM  Trump presses for coronavirus vaccine by end of year MarketWatch
06:46AM  French governments Sanofi bashing smacks of hypocrisy MarketWatch
May-14-20 02:05PM  GlaxoSmithKline's Relative Strength Rating Flashes Healthy Signs Investor's Business Daily
01:27PM  Pluralsight, Stanley Black Decker, Gilead, Regeneron and GlaxoSmithKline as Zacks Bull and Bear of the Day Zacks
11:51AM  Coronavirus Vaccine Progress Accelerates Yahoo Finance
11:33AM  Three Dividend Growth Stocks We Recently Purchased for Our Portfolio GuruFocus.com
11:16AM  WRAPUP 3-France defends equal access to any vaccine as U.S. eyes its own plans Reuters
08:47AM  Sanofi CEO Says Americans to Get Potential Virus Vaccine First SmarterAnalyst
May-13-20 11:11PM  WHO officials grim outlook on COVID-19: This virus may never go away MarketWatch
07:38PM  Trump set to name former Glaxo exec as vaccine czar MarketWatch
04:51PM  U.S. Cases Rise 1.6%, Less Than 1.9% Week Average: Virus Update Bloomberg
04:42PM  Sanofi to accelerate European COVID-19 vaccine access after CEO prioritizes U.S. preorders Reuters
11:57AM  A Look at the Deep Value Stocks of Kahn Brothers GuruFocus.com
08:16AM  Biotech Companies Lead Search for Coronavirus Vaccine: 4 Winners Zacks
May-11-20 10:53AM  Mylan (MYL) Beats on Q1 Earnings on Coronavirus-Led Stockpiling Zacks
05:38AM  European stocks turn lower after early advance MarketWatch
May-10-20 09:47AM  3 Dividend Stocks to Buy That Are Doing Well During the COVID-19 Pandemic Motley Fool
May-08-20 06:16PM  Translate Bio Boosted by Sanofi Vaccine Agreement GuruFocus.com
11:42AM  Pharma Companies Have To Hit A Bull's-Eye To Launch Coronavirus Vaccine In 2021 Investor's Business Daily
08:25AM  3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline InvestorPlace
May-07-20 01:57PM  Theravance (TBPH) Q1 Earnings Miss, Revenues Beat Estimates Zacks
11:24AM  Akebia Shares Climb on Positive Anemia Drug Study Results GuruFocus.com
09:31AM  GSK tests experimental drug to treat pneumonia from COVID-19 Reuters
03:10AM  Britain's GSK to sell entire stake in Hindustan Unilever Reuters
03:10AM  Britain's GSK to sell entire stake in Hindustan Unilever Reuters
May-06-20 02:50PM  These 23 companies are working on coronavirus treatments or vaccines heres where things stand MarketWatch
11:17AM  Clovis (CLVS) Q1 Earnings and Revenues Surpass Estimates Zacks
11:11AM  Pound slumps after construction sector sees worst decline on record MarketWatch
09:35AM  GSK sells $3.4 billion Hindustan Unilever stake in largest India block trade Reuters
09:35AM  GSK selling $3.45 billion stake in Hindustan Unilever - term sheet Reuters
08:17AM  GSK declines to comment on report it is selling $3.4 billion stake in Hindustan Unilever Reuters
May-05-20 11:16PM  Exclusive: Sanofi to enroll thousands for its coronavirus vaccine trials Reuters
May-03-20 04:13AM  GlaxoSmithKline plc Just Beat EPS By 49%: Here's What Analysts Think Will Happen Next Simply Wall St.
May-01-20 05:18PM  Pressure Is Mounting on Regulators as Covid-19 Drug Efforts Race Ahead Barrons.com
Apr-30-20 10:44AM  Glaxo (GSK) Q1 Earnings Beat on COVID-19-Related Stockpiling Zacks
09:37AM  Hedge Fund Manager: Now Isnt The Right Time To Buy GlaxoSmithKline plc (GSK) Insider Monkey
09:11AM  Here's Why Investors Should Follow Sanofi and GlaxoSmithKline's New Coronavirus Collaboration Motley Fool
08:51AM  Remdesivir Progresses on Coronavirus Trial: Pharma Upbeat Zacks
07:19AM  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1 Benzinga
Apr-29-20 06:31PM  GlaxoSmithKline plc (GSK) Q1 2020 Earnings Call Transcript Motley Fool
04:13PM  FDA approves Zejula (niraparib) as the only once-daily PARP inhibitor in first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer regardless of biomarker status PR Newswire
04:05PM  U.S. FDA gives broader approval to GSK's Zejula for ovarian cancer Reuters
11:28AM  GSK, AstraZeneca see virus-crisis boost Reuters Videos
09:07AM  GSK boss does not see mass-produced coronavirus vaccine before mid-2021 Reuters
08:03AM  Glaxo (GSK) Beats Earnings & Revenue Estimates in Q1 Zacks
07:40AM  Glaxo Plans Sale of $3.7 Billion Stake in Unilever India Bloomberg
07:26AM  GSK plans to sell stake in Unilever's India unit - Bloomberg News Reuters
07:18AM  GSK surpasses profit expectations on pain medication stockpiling Reuters
06:00AM  3 Healthcare Stocks With Solid Dividends to Hold Through Bumpy Times Motley Fool
Apr-28-20 11:58AM  What's in Store for Innoviva (INVA) This Earnings Season? Zacks
10:31AM  Good News on Oxford Vaccine Is Bright Spot in Somber Covid-19 Landscape Barrons.com
10:28AM  Will Strong HIV Sales Drive Gilead's (GILD) Q1 Earnings? Zacks
07:02AM  Better Buy: Inovio Pharmaceuticals vs. GlaxoSmithKline Motley Fool
Apr-27-20 05:50PM  GlaxoSmithKline (GSK) Gains But Lags Market: What You Should Know Zacks
02:10PM  Here Are the Latest Updates on 9 Experimental Treatments for the Covid-19 Coronavirus Barrons.com
11:01AM  Is a Beat in Store for Perrigo (PRGO) This Earnings Season? Zacks
Apr-24-20 10:26AM  Is a Beat in Store for Glaxo (GSK) This Earnings Season? Zacks
08:42AM  Sanofi (SNY) Q1 Earnings, Sales Grow on Coronavirus-Led Buying Zacks
08:38AM  The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO Benzinga
Apr-23-20 08:03PM  GSK Presents New Data from the GARNET Study Demonstrating Potential of Dostarlimab to Treat a Subset of Women with Recurrent or Advanced Endometrial Cancer Business Wire
11:02AM  Factors Setting the Tone for Novartis' (NVS) Q1 Earnings Zacks
10:55AM  What's in the Cards for Pfizer (PFE) This Earnings Season? Zacks
10:29AM  Merck (MRK) to Report Q1 Earnings: What's in the Cards? Zacks
08:45AM  European firms step up COVID-19 vaccines work, UK team starts human trials Reuters
Apr-22-20 10:40AM  Sanofi (SNY) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-21-20 05:50PM  GlaxoSmithKline (GSK) Stock Moves -1.61%: What You Should Know Zacks
12:47PM  Can Lilly (LLY) Deliver a Beat in Coronavirus-Hit Q1 Earnings? Zacks
Apr-20-20 09:17AM  The Zacks Analyst Blog Highlights: Netflix, Costco, GlaxoSmithKline, Johnson & Johnson and Cigna Zacks
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; and Sanofi SA. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLCFormer 10% OwnerOct 18Buy28.00357,1429,999,9762,982,855Oct 22 05:36 PM
GLAXOSMITHKLINE PLCDirectorSep 10Buy45.00177,7777,999,9652,170,327Sep 12 04:18 PM
GLAXOSMITHKLINE PLCDirectorJul 01Buy15.00333,3334,999,9952,633,772Jul 02 04:13 PM
GLAXOSMITHKLINE PLCDirectorMay 28Buy14.00385,7145,399,9961,915,275May 30 05:47 PM